| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |